When Merck purchased OncoImmune to gain control of the experimental treatment for COVID-19, and shortly after signed a $356 million dollar government contract to deliver 100,000 doses by the summer, it was assumed that Merck would be able to deliver. However, despite positive trial data, the FDA is demanding that there be more evidence of […]
Industry News
With Demands for Additional Data, the FDA Pauses Merck’s MK-7110 Summer Rollout
August 9th, 2021 | Industry NewsNovel Retinal Disease Treatments? Iveric Bio Begins the Search for Potential Gene Therapies
August 4th, 2021 | Industry News
To help tackle the difficulty of finding treatments for retinal diseases, Iveric Bio has established the “Gene Therapy Inherited Retina Disease Scientific Advisory Committee” to help translate research findings into actionable, clinical solutions. The committee is comprised of a specialized group of experts, all of whom focus in a specific niche. The committee is centrally […]
The Impact of the Immune System: How studying the immune reactions to COVID-19 will help scientists to develop more effective vaccines
July 27th, 2021 | Industry News
As the first round of approved vaccines makes its’ way into arms around the world, scientists are still working tirelessly to find improved vaccines for years to come. One key avenue through which scientists are looking to make improvements is in the interactions between cells infected with SARS-CoV-2 and the human immune system. Studying these […]
The Impact of the Immune System: How studying the immune reactions to COVID-19 will help scientists to develop more effective vaccines
July 21st, 2021 | Industry NewsAs the first round of approved vaccines makes its’ way into arms around the world, scientists are still working tirelessly to find improved vaccines for years to come. One key avenue through which scientists are looking to make improvements is in the interactions between cells infected with SARS-CoV-2 and the human immune system. Studying these […]
Novel Retinal Disease Treatments? Iveric Bio Begins the Search for Potential Gene Therapies
July 15th, 2021 | Industry NewsTo help tackle the difficulty of finding treatments for retinal diseases, Iveric Bio has established the “Gene Therapy Inherited Retina Disease Scientific Advisory Committee” to help translate research findings into actionable, clinical solutions. The committee is comprised of a specialized group of experts, all of whom focus in a specific niche. The committee is centrally involved with the gene […]
With Demands for Additional Data, the FDA Pauses Merck’s MK-7110 Summer Rollout
July 8th, 2021 | Industry News
When Merck purchased OncoImmune to gain control of the experimental treatment for COVID-19, and shortly after signed a $356 million dollar government contract to deliver 100,000 doses by the summer, it was assumed that Merck would be able to deliver. However, despite positive trial data, the FDA is demanding that there be more evidence of the drug’s effect […]
We are Hiring – Open Contractor Positions at MVG Consulting
February 8th, 2021 | Industry NewsLooking for new consulting work? Check out our open contractor positions at MVG: Manager of Clinical Quality Systems Clinical Quality Assurance Auditor Clinical Trial Manager Clinical Project Manager Medical Writer Contact MVG today with inquiries!
How Covid-19 could drive a shift toward decentralized clinical trials
December 7th, 2020 | Industry NewsHeading towards the inevitable? COVID-19 paves the way for decentralized trials The pandemic has become a showcase for decentralized research that uses telemedicine and mobile tools to accelerate the pace of discovery. Source: How Covid-19 could drive a shift toward decentralized clinical trials
Virtual Pharma: How Technology is Paving the Way for Increased Innovation
November 23rd, 2020 | Industry NewsTechnological innovation within the Pharmaceutical industry is on a clear path towards continued growth, and with that comes the opportunity for new players to get involved. Outside of speed and efficiency, the integration of technology also allows increased accessibility for companies perhaps not otherwise suited to infiltrate the industry. Virtual Pharma companies are a great […]
Rapid Scientific Innovation Begs the Question of Integrity
November 16th, 2020 | Industry NewsThe speed with which COVID-19 vaccines are being developed leaves many uncertain about the safety and effectiveness of a potential vaccine. The global conference hosted by Harvard and MIT confronts this uncertainty and probes the question of how to evaluate and regulate drug development moving forward. Technology will play a central role in upcoming innovation, […]